The unique GPCR primary cells screening platform
Arcoscreen’s mission is to help pharmaceutical companies identify promising G protein Coupled Receptor (GPCR) drugs in primary cells to get faster from research to clinical trials.
Our services
-
Drug mode of action identification in primary cells
-
GPCR activation identification in primary cells with GTPγS assay
-
Ready to use or custom GPCR stable cell lines
“An in-vivo predictability at the in-vitro step!”
Our technology
Our technology enables the access to the essential actors of the GPCR activation inside any mammalian cell. For the first time ever, drugs and their effects can be tested on chip with cells taken directly from living tissue. Our dual innovation combines a novel biological assay embedded in a microfluidic chip!
